If you experience any unexpected symptoms after administration including nausea, vomiting, injection site swelling or redness, signs of allergic reaction (rash, difficulty breathing, swelling of the face or throat), or systemic symptoms such as fever you should: Contact your GP promptly for non-urgent concerns Call NHS 111 if you are unsure whether your symptoms require urgent attention Call 999 or attend A&E immediately if you experience a severe allergic reaction, chest pain, difficulty breathing, or loss of consciousness Suspected side effects or adverse reactions to any medicine, including investigational products, should be reported to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk
Novo Nordisk continues to invest heavily in next-generation obesity treatments and expanded indications, reinforcing its competitive advantage and long-term growth in this therapeutic area.
The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases
Indiana Capital Chronicle maintains editorial independence
Among them, Eli Lilly's Tirzepatide stands out